Altshuler Shaham’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.9K Buy
61
+37
+154% +$18.9K ﹤0.01% 213
2026
Q2
$11.9K Buy
24
+15
+167% +$6.65K ﹤0.01% 316
2026
Q1
$4.02K Buy
+9
New +$4.2K ﹤0.01% 323
2025
Q4
– Sell
-3,020
Closed -$1.18M – 470
2025
Q3
$1.18M Hold
3,020
– – 0.02% 76
2025
Q2
$1.34M Hold
3,020
– – 0.04% 65
2025
Q1
$1.46M Hold
3,020
– – 0.04% 51
2024
Q4
$1.22M Buy
+3,020
New +$1.4M 0.04% 48
2024
Q3
– Sell
-3,000
Closed -$1.41M – 362
2024
Q2
$1.41M Sell
3,000
-655
-18% -$284K 0.05% 42
2024
Q1
$1.53M Sell
3,655
-847
-19% -$358K 0.06% 34
2023
Q4
$1.83M Buy
4,502
+4,435
+6,619% +$1.64M 0.1% 22
2023
Q3
$23.3K Sell
67
-19
-22% -$6.64K ﹤0.01% 211
2023
Q2
$30.3K Buy
+86
New +$29K ﹤0.01% 233
2023
Q1
– Sell
-513
Closed -$148K – 464
2022
Q4
$148K Sell
513
-184
-26% -$56.1K 0.01% 109
2022
Q3
$204K Sell
697
-119
-15% -$34.2K 0.01% 124
2022
Q2
$230K Sell
816
-225
-22% -$60.2K ﹤0.01% 125
2022
Q1
$272K Buy
+1,041
New +$247K ﹤0.01% 193
2021
Q3
– Sell
-140
Closed -$28K – 675
2021
Q2
$28K Buy
+140
New +$29.3K ﹤0.01% 519
2020
Q4
– Sell
-443
Closed -$121K – 474
2020
Q3
$121K Sell
443
-1,248
-74% -$344K ﹤0.01% 163
2020
Q2
$491K Sell
1,691
-505
-23% -$137K 0.01% 102
2020
Q1
$523K Buy
2,196
+2,054
+1,446% +$471K 0.02% 84
2019
Q4
$31K Buy
142
+82
+137% +$16.6K ﹤0.01% 219
2019
Q3
$10K Buy
+60
New +$10.6K ﹤0.01% 282
2019
Q2
– Sell
-44
Closed -$8K – 400
2019
Q1
$8K Sell
44
-1
-2% -$185 ﹤0.01% 269
2018
Q4
$7K Buy
+45
New +$7.8K ﹤0.01% 244

Other funds holding VRTX

Altshuler Shaham's VRTX Position: Q3 2026 in Review

Altshuler Shaham increased its Vertex Pharmaceuticals (VRTX) stake by 154% in Q3 2026, buying an estimated $18.9K and bringing the position to 61 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #213.

Altshuler Shaham first reported a position in VRTX in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.83M in Q4 2023. 1,797 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Altshuler Shaham held 61 shares of Vertex Pharmaceuticals worth $31.9K as of Q3 2026.
  • Altshuler Shaham bought 37 Vertex Pharmaceuticals shares in Q3 2026, an estimated $18.9K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Altshuler Shaham's portfolio in Q3 2026, its #213 holding.
  • Altshuler Shaham first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 24 quarters since.
  • Altshuler Shaham's Vertex Pharmaceuticals position peaked at $1.83M in Q4 2023.
  • 1,797 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Altshuler Shaham's 13F filing for Q3 2026, filed 12 Nov 2026.